XML 20 R14.htm IDEA: XBRL DOCUMENT
v3.26.1

Balance Sheet Components | 6 Months Ended
--- | ---
Jun. 30, 2026
Balance Sheet Related Disclosures [Abstract] |
Balance Sheet Components | 6. Balance Sheet Components Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands):
|  | June 30, |  |  | December 31, |
|  | 2026 |  |  | 2025 |
Accrued external research and development expenses |  | $ | 262 |  |  | $ | 280 |
Accrued compensation |  |  | 2,253 |  |  |  | 2,888 |
Accrued consulting and professional fees |  |  | 915 |  |  |  | 875 |
Accrued financing costs |  |  | 4 |  |  |  | 3,326 |
Accrued other |  |  | 250 |  |  |  | 164 |
Total accrued expenses and other current liabilities |  | $ | 3,684 |  |  | $ | 7,533 |
Deposits and Other Non-Current Assets Deposits and other non-current assets primarily include deposits related to clinical trials of $6.6 million and $3.2 million as of June 30, 2026 and December 31, 2025, respectively. Other Non-Current Liabilities Other non-current liabilities primarily include liabilities related to uncertain tax positions of $0.8 million as of June 30, 2026 and December 31, 2025.

X
- References No definition available. + Details
Name: | us-gaap_BalanceSheetRelatedDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration